Madrigal Pharmaceuticals Financial Overview
Madrigal Pharmaceuticals's market cap is currently $13.68B. The company's EPS TTM is $-5.08; its P/E ratio is -46.30; Madrigal Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.91. See an overview of income statement, balance sheet, and cash flow financials.
